M

Magle Chemoswed Holding AB
STO:MAGLE

Watchlist Manager
Magle Chemoswed Holding AB
STO:MAGLE
Watchlist
Price: 32.6 SEK -4.12% Market Closed
Market Cap: 599.9m SEK
Have any thoughts about
Magle Chemoswed Holding AB?
Write Note

Magle Chemoswed Holding AB
Other Non-Cash Items

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Magle Chemoswed Holding AB
Other Non-Cash Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Non-Cash Items CAGR 3Y CAGR 5Y CAGR 10Y
M
Magle Chemoswed Holding AB
STO:MAGLE
Other Non-Cash Items
-kr955k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
AddLife AB
STO:ALIF B
Other Non-Cash Items
-kr211m
CAGR 3-Years
N/A
CAGR 5-Years
-114%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Other Non-Cash Items
-kr202.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Other Non-Cash Items
kr17m
CAGR 3-Years
120%
CAGR 5-Years
N/A
CAGR 10-Years
19%
G
Genovis AB
STO:GENO
Other Non-Cash Items
kr11.8m
CAGR 3-Years
32%
CAGR 5-Years
22%
CAGR 10-Years
27%
MedCap AB (publ)
STO:MCAP
Other Non-Cash Items
-kr29.6m
CAGR 3-Years
-55%
CAGR 5-Years
-59%
CAGR 10-Years
N/A
No Stocks Found

Magle Chemoswed Holding AB
Glance View

Market Cap
599.9m SEK
Industry
Life Sciences Tools & Services

Magle Chemoswed Holding AB engages in the provision of contract development and manufacturing services to the pharmaceutical and medical device industry. The company is headquartered in Malmo, Skane. The company went IPO on 2020-06-30. The firm's operations are mainly conducted through the subsidiaries Magle Chemoswed AB and Adroit Science AB. The business is focused on process development and manufacturing of Active Pharmaceutical Ingredients (API) as well as research, development and manufacturing of products in the areas of wound care and diagnostics with particular focus on products based on degradables starch microspheres. Magle Chemoswed also functions as a consultancy in material characterization and solid phase analysis with a main focus on pharmaceutical companies.

MAGLE Intrinsic Value
83.52 SEK
Undervaluation 61%
Intrinsic Value
Price
M

See Also

What is Magle Chemoswed Holding AB's Other Non-Cash Items?
Other Non-Cash Items
-955k SEK

Based on the financial report for Dec 31, 2023, Magle Chemoswed Holding AB's Other Non-Cash Items amounts to -955k SEK.

Back to Top